Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-17-000009

Chief Medical Officer gave up 7,648 shares (to pay taxes)

  • Chief Medical Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bagarazzi Mark · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-09 Exercise or conversion : show line 1 in the form +25,000 50,758 D
2017-03-09 Shares withheld for taxes : show line 2 in the form −7,648 $6.61 $50,553 43,110 D

Table II: Derivative

3 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2017-03-09 Exercise or conversion : show line 3 in the form Restricted Stock Unit −25,000 25,000 50,000 D
2017-03-10 Grant or award : show line 4 in the form Common Stock Options +100,000 $6.68 $668,000 $6.68 2027-03-10 100,000 100,000 D
2017-03-10 Grant or award : show line 5 in the form Restricted Stock Unit +61,300 61,300 61,300 D
Loading xslF345X03/wf-form4_148944135554499.xml…